Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of coumarin biosynthesis in modulating plant drought responses: insights from PpBMT overexpression in Arabidopsis.

BMC plant biology·2026
Same author

Unconventional Zero-Field-Cooling Exchange Bias in 2D Van der Waals Magnetic Heterostructures.

Nano letters·2026
Same author

The application of probe-based confocal laser endomicroscopy in pleural diseases.

Medicine·2026
Same author

uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications.

Cells·2026
Same author

Causal effects of obesity on urolithiasis and the mediating role of inflammatory factors: A two-sample Mendelian randomization study.

Medicine·2026
Same author

Silicon mitigates aluminum toxicity in lettuce by improving photosynthetic pigments and antioxidant defense system.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2026

Related Experiment Video

Updated: Jun 19, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells.

Keith P Moore1, Adam G Schwaid1, Matthew Tudor2

  • 1Chemical Biology, Merck & Co., Inc., Rahway, New Jersey 07065, United States.

ACS Chemical Biology
|August 31, 2022
PubMed
Summary

Researchers discovered novel compounds that induce cell death in HIV-1 infected cells by targeting DPP9 and CARD8 inflammasome. This approach, synergistic with efavirenz, offers a potential strategy for HIV-1 eradication by engaging the pyroptotic pathway.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.8K

Related Experiment Videos

Last Updated: Jun 19, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.8K

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Current antiretroviral therapy (ART) effectively controls HIV-1 replication but does not eliminate persistent viral reservoirs, hindering curative strategies.
  • Eradicating latent HIV-1 reservoirs is a critical challenge for achieving a functional cure in people living with HIV-1 (PLWH).

Purpose of the Study:

  • To identify novel chemical compounds capable of eliminating HIV-1 infected cells.
  • To elucidate the mechanism of action of these compounds and their potential for synergistic therapy.

Main Methods:

  • Phenotypic screening to identify compounds targeting HIV-1 infected cells.
  • Chemoproteomic, biochemical, pharmacological, and genetic approaches to determine the mechanism of action.
  • In vitro synergy studies with efavirenz.

Main Results:

  • A novel chemical class, including compounds ICeD-1 and ICeD-2, was identified to kill HIV-1 infected peripheral blood mononuclear cells.
  • These compounds modulate dipeptidyl peptidase 9 (DPP9) and activate the caspase recruitment domain family member 8 (CARD8) inflammasome.
  • Efficacy was dependent on HIV-1 protease activity and synergistic with efavirenz, lowering its effective concentration.

Conclusions:

  • Engagement of the pyroptotic pathway via DPP9 modulation and CARD8 inflammasome activation presents a potential strategy for HIV-1 reservoir eradication.
  • The synergy between ICeD compounds and efavirenz suggests a promising therapeutic approach for achieving HIV-1 cure.